Cyfuse Biomedical Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Public

  • Employees
  • 26

Employees

  • Stock Symbol
  • 4892

Stock Symbol

  • Share Price
  • $3.16
  • (As of Thursday Closing)

Cyfuse Biomedical General Information

Description

Cyfuse Biomedical KK is engaged in the development, manufacturing, and sales of regenerative medicine-related products. The company focuses on delivering three-dimensional tissues and organs created solely from cells as new 3D cell products to medical fields, including regenerative medicine and drug discovery, through the practical application of three-dimensional cell stacking technology. It is engaged in multifaceted development in the following areas: regenerative medicine, drug discovery support, and the device domain, including the development and sales of 3D cell stacking system equipment, such as bio 3D printers equipped with the company's platform technology.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • South Tower, Sumitomo Fudosan Tokyo Mita
  • 3-5-27 Mita, Minato-ku
  • Tokyo, 108-6301
  • Japan
+81
Primary Industry
Biotechnology
Other Industries
Machinery (B2B)
Discovery Tools (Healthcare)
Other Devices and Supplies
Stock Exchange
TKS
Vertical(s)
Corporate Office
  • South Tower, Sumitomo Fudosan Tokyo Mita
  • 3-5-27 Mita, Minato-ku
  • Tokyo, 108-6301
  • Japan
+81

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cyfuse Biomedical Stock Performance

As of 19-Nov-2026, Cyfuse Biomedical’s stock price is $3.16. Its current market cap is $31.8M with 10.1M shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.16 $3.23 $2.98 - $4.79 $31.8M 10.1M 52.8K -$0.53

Cyfuse Biomedical Financials Summary

As of 30-Jun-2026, Cyfuse Biomedical has a trailing 12-month revenue of $1.98M.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 19,688 17,581 6,927 20,745
Revenue 1,981 1,543 360 435
EBITDA (4,843) (4,779) (5,445) (3,831)
Net Income (5,154) (5,104) (5,759) (4,193)
Total Assets 24,244 27,272 22,403 29,886
Total Debt 7,614 8,387 5,431 6,474
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Cyfuse Biomedical Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Cyfuse Biomedical‘s full profile, request access.

Request a free trial

Cyfuse Biomedical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Cyfuse Biomedical KK is engaged in the development, manufacturing, and sales of regenerative medicine-related products.
Biotechnology
Tokyo, Japan
26 As of 2025

Bridgewater, NJ
 

Molndal, Sweden
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Cyfuse Biomedical Competitors (15)

One of Cyfuse Biomedical’s 15 competitors is 3D Biotek, a Corporate Backed or Acquired company based in Bridgewater, NJ.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
3D Biotek Corporate Backed or Acquired Bridgewater, NJ
Fluicell Formerly VC-backed Molndal, Sweden
Aspect Biosystems Venture Capital-Backed Vancouver, Canada
Histogen Formerly VC-backed San Ramon, CA
Synthecon Formerly Accelerator/Incubator backed Houston, TX
You’re viewing 5 of 15 competitors. Get the full list »

Cyfuse Biomedical Patents

Cyfuse Biomedical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026197045-A1 Method for evaluating periodontal tissue regeneration ability of cell structure for transplantation Pending 19-Mar-2025
WO-2026127150-A1 Liver-like or liver tissue-like structure Pending 09-Dec-2024
JP-2025140768-A Cryopreservation method for tublar cell structure, cryopreservation tool and frozen substance Pending 14-Mar-2024
JP-2024156287-A Angle adjustment mechanism and puncture device Pending 24-Apr-2023
JP-2024151045-A Dispensing device Pending 11-Apr-2023
To view Cyfuse Biomedical’s complete patent history, request access »

Cyfuse Biomedical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cyfuse Biomedical Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Cyfuse Biomedical‘s full profile, request access.

Request a free trial

Cyfuse Biomedical ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view Cyfuse Biomedical’s complete esg history, request access »

Cyfuse Biomedical FAQs

  • When was Cyfuse Biomedical founded?

    Cyfuse Biomedical was founded in 2010.

  • Where is Cyfuse Biomedical headquartered?

    Cyfuse Biomedical is headquartered in Tokyo, Japan.

  • What is the size of Cyfuse Biomedical?

    Cyfuse Biomedical has 26 total employees.

  • What industry is Cyfuse Biomedical in?

    Cyfuse Biomedical’s primary industry is Biotechnology.

  • Is Cyfuse Biomedical a private or public company?

    Cyfuse Biomedical is a Public company.

  • What is Cyfuse Biomedical’s stock symbol?

    The ticker symbol for Cyfuse Biomedical is 4892.

  • What is the current stock price of Cyfuse Biomedical?

    As of 19-Nov-2026 the stock price of Cyfuse Biomedical is $3.16.

  • What is the current market cap of Cyfuse Biomedical?

    The current market capitalization of Cyfuse Biomedical is $31.8M.

  • What is Cyfuse Biomedical’s current revenue?

    The trailing twelve month revenue for Cyfuse Biomedical is $1.98M.

  • Who are Cyfuse Biomedical’s competitors?

    3D Biotek, Fluicell, Aspect Biosystems, Histogen, and Synthecon are some of the 15 competitors of Cyfuse Biomedical.

  • What is Cyfuse Biomedical’s annual earnings per share (EPS)?

    Cyfuse Biomedical’s EPS for 12 months was -$0.53.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process